Retrospective Cohort Study: Racial and ethnic discrepancy in pulse oximetry and delayed identification of treatment eligibility among patients with COVID-19.

Racial and Ethnic Discrepancy in Pulse Oximetry and Delayed Identification of Treatment Eligibility Among Patients With COVID-19 – JAMA Internal Medicine

Editorial: Racial and Ethnic Bias in Pulse Oximetry and Clinical Outcomes

Commentary: Study: Pulse oximeter devices overestimated blood oxygen levels in non-White patients with COVID-19 – News Medical

Related:

Racial Bias in Pulse Oximetry Measurement – New England Journal of Medicine

Pulse Oximetry for Monitoring Patients with Covid-19 at Home — A Pragmatic, Randomized Trial – New England Journal of Medicine

Effectiveness and safety of pulse oximetry in remote patient monitoring of patients with COVID-19: a systematic review – The Lancet Digital Health

FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias – STAT

Pulse Oximeter Accuracy and Limitations: FDA Safety Communication – U.S. Food & Drug Administration

Commentary on Twitter

This cohort study found overestimation of arterial oxygen saturation levels by pulse oximetry occurred in Asian, Black, and Hispanic patients with #COVID19 and delayed care compared with White patients. https://t.co/ptOVwuUewr @AshFawzyMD @GoldenSherita @AmandaBradke @BTGaribaldi

— JAMA Internal Medicine (@JAMAInternalMed) May 31, 2022